Background illustration for clinical trials search

Paid Clinical Trials Indianapolis

Discover 874 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Indianapolis IN, Cincinnati OH, Dayton OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Indianapolis IN, Dayton OH, Lexington KY, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase2, Recruiting

Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen

for
Constipation
Location: Indianapolis IN, Carmel IN
Sponsor: Indiana University

Sex: All

Age: 2 - 18

Code: NCT05821309

Recruiting

TrialNet Pathway to Prevention of T1D

for
Diabetes Mellitus, Type 1
Location: Indianapolis IN, Nashville TN, Pittsburgh PA,
Sponsor: University of South Florida

Sex: All

Age: 2 - 45

Code: NCT00097292

Recruiting

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

for
Type 1 Diabetes Mellitus, T1D, T1DM,
Location: Indianapolis IN, Chicago IL, Springfield IL,
Sponsor: COUR Pharmaceutical Development Company, Inc.

Sex: All

Age: 12 - 35

Code: NCT06783309

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Indianapolis IN, Lexington KY, Chicago IL,
Sponsor: Children's Oncology Group

Sex: All

Age: 15 - 20

Code: NCT06410209

Phase2, Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Indianapolis IN, Cincinnati OH, Louisville KY,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT01351545

Recruiting

Comparison of Uncomplicated Candidemia Therapy Duration in Children

for
Invasive Candidiasis
Location: Indianapolis IN, Cincinnati OH, Chicago IL, Columbus OH,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0+

Code: NCT05763251

Recruiting

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

for
Autoimmune Hepatitis, Primary Sclerosing Cholangitis
Location: Indianapolis IN, Cincinnati OH, Columbus OH,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0+

Code: NCT05750498

Recruiting

A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment

for
Noonan Syndrome
Location: Indianapolis IN, Cincinnati OH, Lexington KY,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06668805

Phase2, Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

for
Stage II Nasopharyngeal Carcinoma AJCC v8,
Location: Indianapolis IN, Cincinnati OH, Dayton OH, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 21

Code: NCT06064097

Phase2, Recruiting

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

for
Failed or Difficult Intubation, Sequela, Intubation; Difficult,
Location: Indianapolis IN, Cincinnati OH, Louisville KY,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT02493478

Recruiting

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

for
B-cell Acute Lymphoblastic Leukemia
Location: Indianapolis IN, Grand Rapids MI, Atlanta GA,
Sponsor: Pediatric Transplantation & Cellular Therapy Consortium

Sex: All

Age: 1 - 25

Code: NCT03509961

Phase2, Recruiting

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

for
Von Willebrand Disease (VWD)
Location: Indianapolis IN, Peoria IL, East Lansing MI, Detroit MI,
Sponsor: Takeda

Sex: All

Age: 0 - 17

Code: NCT05582993

Phase3, Recruiting

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

for
Crohn's Disease
Location: Indianapolis IN, Dayton OH, London, Atlanta GA, Toronto,
Sponsor: Eli Lilly and Company

Sex: All

Age: 2 - 17

Code: NCT05509777

Phase3, Recruiting

An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics

for
Hyperammonemia, Methylmalonic Acidemia, Propionic Acidemia
Location: Indianapolis IN, Chicago IL, Washington DC, New York NY,
Sponsor: Recordati Rare Diseases

Sex: All

Age: 0+

Code: NCT05040178

Recruiting

Personalized Perioperative Analgesia Platform (PPAP) for Pediatric Spine Fusion Surgery (sIRB)

for
PPAP, Spine Fusion
Location: Indianapolis IN, Pittsburgh PA, San Francisco CA
Sponsor: Senthil Sadhasivam

Sex: All

Age: 10 - 21

Code: NCT05367609

Recruiting

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Indianapolis IN, Cincinnati OH, Dayton OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 2 - 21

Code: NCT04166409

Phase3, Recruiting

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Indianapolis IN, Cincinnati OH, Dayton OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 25

Code: NCT03959085

Phase3, Recruiting

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

for
Embryonal Rhabdomyosarcoma,
Location: Indianapolis IN, Cincinnati OH, Dayton OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT05304585

Phase3, Recruiting